13:10:03 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-02-20 Bokslutskommuniké 2023
2023-11-07 Kvartalsrapport 2023-Q3
2023-08-18 Kvartalsrapport 2023-Q2
2023-04-26 Ordinarie utdelning BIOS 0.00 SEK
2023-04-25 Årsstämma 2023
2023-04-25 Kvartalsrapport 2023-Q1
2023-02-22 Bokslutskommuniké 2022
2022-11-15 Kvartalsrapport 2022-Q3
2022-09-19 Extra Bolagsstämma 2022
2022-08-31 Kvartalsrapport 2022-Q2
2022-05-04 Ordinarie utdelning BIOS 0.00 SEK
2022-05-03 Kvartalsrapport 2022-Q1
2022-05-03 Årsstämma 2022
2022-02-17 Bokslutskommuniké 2021
2021-11-09 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-05-04 Kvartalsrapport 2021-Q1
2021-04-20 Ordinarie utdelning BIOS 0.00 SEK
2021-04-19 Årsstämma 2021
2021-02-23 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-05-08 Ordinarie utdelning BIOS 0.00 SEK
2020-05-07 Kvartalsrapport 2020-Q1
2020-05-07 Årsstämma 2020
2020-02-21 Bokslutskommuniké 2019
2019-11-05 Kvartalsrapport 2019-Q3
2019-09-10 Extra Bolagsstämma 2019
2019-08-13 Kvartalsrapport 2019-Q2
2019-05-10 Ordinarie utdelning BIOS 0.00 SEK
2019-05-06 Kvartalsrapport 2019-Q1
2019-05-06 Årsstämma 2019
2019-02-19 Bokslutskommuniké 2018
2018-11-06 Kvartalsrapport 2018-Q3
2018-10-02 Extra Bolagsstämma 2018
2018-08-24 Kvartalsrapport 2018-Q2
2018-05-03 Ordinarie utdelning BIOS 0.00 SEK
2018-05-02 Årsstämma 2018
2018-05-02 Kvartalsrapport 2018-Q1
2018-02-26 Bokslutskommuniké 2017
2017-11-16 Kvartalsrapport 2017-Q3
2017-08-17 Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorIndustri
IndustriIndustriprodukter
Bioservo Technologies är ett teknikbolag inriktade mot hälsovårdssektorn. Bolaget utvecklar robotteknologi anpassat för personer som lider utav nedsatt muskelstyrka. Teknologin baseras på den framtagna SEM-teknologin (Soft Extra Muscle), som används för att hantera patientens uthållighet. Ett exempel är bolagets servohandske som är anpassad för personer med nedsatt funktion i händerna. Bolaget grundades 2006 och har sitt huvudkontor i Kista.
2023-05-05 14:00:00

[image]

On May 10 at 13:45, Bioservo's CEO, Petter Bäckgren, will present the latest news from the company at Redeye Medtech Event. The presentation will be broadcast live and can be followed on https://www.redeye.se/events/870864/redeye-medtech-event where the recording and presentations will also be available afterward.

Bioservo is a world-leading company in portable, muscle-strengthening systems for the hands that is entering an exciting expansion phase. During the first quarter, the company began delivering a completely new generation of Carbonhand to patients with impaired hand function and distributors in Europe and Australia, and in the industrial segment, interest in Ironhand is growing after, for example, the foundry group Waupaca introduced the systems at several production facilities.

In April, the company made Carbonhand available as a medical device in the US and has begun work on establishing a partner network to commercialize the product in the US market, which represents over 40% of the market for medical devices.

This and more will be presented at the Redey Medtech Event on May 10th.

For more information, please contact,
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
petter.backgren@bioservo.com

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10
mikael.wester@bioservo.com

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world-leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health of workers and to improve the quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.com